Drug Profile


Alternative Names: FCE 25388; THF-gamma2; Thymic humoral factor; Thymic humoral factor gamma-2

Latest Information Update: 06 Dec 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmacia Corporation
  • Developer Nonindustrial source; Pharmacia Corporation; Yeda
  • Class Antivirals; Peptides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; HIV infections; Viral infections

Most Recent Events

  • 27 Feb 2001 A preclinical study has been added to the Cancer pharmacodynamics filed
  • 30 Mar 2000 Discontinued-II for HIV infections treatment in France (Unknown route)
  • 30 Mar 2000 Discontinued-II for HIV infections treatment in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top